Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical Trial, Phase I”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03562871
What this trial is testing

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Who this might be right for
NSCLC
IO Biotech 109
Testing effectiveness (Phase 2)UnknownNCT02848417
What this trial is testing

Glutathione vs. Curcumin Clinical Trial

Who this might be right for
Gulf War Syndrome
South Florida Veterans Affairs Foundation for Research and Education 75
Early research (Phase 1)Study completedNCT00091325
What this trial is testing

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Arizona
Early research (Phase 1)Study completedNCT03205917
What this trial is testing

A Clinical Trial of PGDM1400 and PGT121 and VRC07-523LS Monoclonal Antibodies in HIV-infected and HIV-uninfected Adults

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 29
Early research (Phase 1)Study completedNCT00002335
What this trial is testing

The Safety and Effectiveness of 524W91

Who this might be right for
HIV Infections
Glaxo Wellcome 18
Testing effectiveness (Phase 2)Study completedNCT03664635
What this trial is testing

MB-CART20.1 Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaB-cell Lymphoma Refractory+1 more
Miltenyi Biomedicine GmbH 10
Early research (Phase 1)Ended earlyNCT03387917
What this trial is testing

TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Swiss Cancer Institute 12
Early research (Phase 1)Not Yet RecruitingNCT07131540
What this trial is testing

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)

Who this might be right for
Acute-On-Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT03754725
What this trial is testing

Ferritin and Iron Burden in SAH sIRB

Who this might be right for
SAHDementia
Duke University 66
Not applicableStudy completedNCT01166308
What this trial is testing

Carbon Ion Radiotherapy for Recurrent Gliomas

Who this might be right for
Glioma
University Hospital Heidelberg 56
Testing effectiveness (Phase 2)WithdrawnNCT00053040
What this trial is testing

Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Very early researchLooking for participantsNCT06045091
What this trial is testing

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
Hrain Biotechnology Co., Ltd. 18
Early research (Phase 1)Study completedNCT01614197
What this trial is testing

A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

Who this might be right for
Lymphoblastic Leukemia, Acute, ChildhoodLymphoblastic LymphomaPeripheral T-cell Lymphoma
Therapeutic Advances in Childhood Leukemia Consortium 16
Early research (Phase 1)Study completedNCT05011097
What this trial is testing

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Wuhan YZY Biopharma Co., Ltd. 20
Early research (Phase 1)Study completedNCT02849210
What this trial is testing

A Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Rhinoconjuncitivis Sensitized to Olea Europaea

Who this might be right for
Rhinoconjunctivitis
Roxall Medicina España S.A 47
Early research (Phase 1)Looking for participantsNCT06156410
What this trial is testing

Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas

Who this might be right for
Ewing SarcomaOsteosarcomaSarcomas
Children's Hospital of Philadelphia 30
Early research (Phase 1)Active Not RecruitingNCT04049513
What this trial is testing

ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)

Who this might be right for
Lymphomas Non-Hodgkin's B-CellDiffuse Large B-cell Lymphoma (DLBCL)Primary Mediastinal B-cell Lymphoma (PMBCL)+3 more
Malaghan Institute of Medical Research 30
Early research (Phase 1)Study completedNCT01878890
What this trial is testing

Phase I Dose Escalation Trial of Efavirenz in Solid Tumours or Non-Hodgkin Lymphoma in Therapeutic Failure.

Who this might be right for
Solid TumorsNon-Hodgkin's Lymphoma
Institut Bergonié 25
Early research (Phase 1)Ended earlyNCT00185874
What this trial is testing

Phase I Intratumoral Dendritic Cell Immunotherapy in Thermally Ablated Liver Metastases

Who this might be right for
Liver Cancer
Stanford University 22
Testing effectiveness (Phase 2)Study completedNCT03112590
What this trial is testing

Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer

Who this might be right for
Breast CancerBreast Cancer, MaleBreast Cancer Female+1 more
H. Lee Moffitt Cancer Center and Research Institute 51
Next Page